| |
| |
|
| Insider
Information: |
Crooke Stanley T |
| Relationship: |
Director, 10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,021 |
|
|
Indirect Shares
|
7,547,002 |
|
|
| Direct
Value |
$75,929 |
|
|
|
Indirect Value
|
$34,834,505 |
|
|
| Total
Shares |
7,549,023 |
|
|
| Total
Value |
$34,910,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Exec Chairman of the B... |
2021-01-26 |
2,021 |
2021-01-26 |
497,502 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
463 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 19
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-09 |
4 |
AS |
$10.26 |
$205,200 |
D/D |
(20,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-10 |
4 |
AS |
$10.15 |
$304,500 |
D/D |
(30,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-10 |
4 |
OE |
$6.81 |
$204,375 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-11 |
4 |
OE |
$6.81 |
$136,250 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-11 |
4 |
AS |
$9.98 |
$199,600 |
D/D |
(20,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-14 |
4 |
OE |
$6.81 |
$136,250 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-14 |
4 |
AS |
$9.86 |
$197,200 |
D/D |
(20,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-15 |
4 |
OE |
$6.81 |
$180,770 |
D/D |
26,535 |
26,535 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-15 |
4 |
AS |
$10.03 |
$266,146 |
D/D |
(26,535) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-16 |
4 |
AS |
$10.11 |
$237,114 |
D/D |
(23,465) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-16 |
4 |
OE |
$6.81 |
$159,855 |
D/D |
23,465 |
23,465 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-22 |
4 |
OE |
$6.81 |
$136,250 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-22 |
4 |
AS |
$10.13 |
$202,600 |
D/D |
(20,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-30 |
4 |
OE |
$6.81 |
$44,503 |
I/I |
6,535 |
6,535 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2009-12-30 |
4 |
AS |
$11.07 |
$72,310 |
I/I |
(6,535) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-22 |
4 |
AS |
$10.52 |
$168,320 |
D/D |
(16,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-22 |
4 |
OE |
$9.63 |
$154,000 |
D/D |
16,000 |
16,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-23 |
4 |
OE |
$9.63 |
$38,500 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-23 |
4 |
AS |
$10.53 |
$42,100 |
D/D |
(4,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-27 |
4 |
OE |
$9.63 |
$192,500 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-27 |
4 |
AS |
$10.42 |
$208,400 |
D/D |
(20,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-29 |
4 |
AS |
$10.32 |
$20,630 |
I/I |
(2,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-29 |
4 |
OE |
$9.63 |
$19,250 |
I/I |
2,000 |
2,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-29 |
4 |
AS |
$10.32 |
$103,150 |
D/D |
(10,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2010-12-29 |
4 |
OE |
$9.63 |
$96,250 |
D/D |
10,000 |
10,000 |
0 |
- |
|
463 Records found
|
|
Page 4 of 19 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
